For patients who want both approaches, a common protocol is: PRP session(s) with an orthopedic provider for the concentrated local stimulus, plus a BPC-157 protocol from Moonshot to sustain the healing environment between PRP sessions
This research-grade BPC-157 and TB-500 blend is studied in regenerative and tissue-repair research
Mechanism of Action This is where the two peptides diverge most clearly: BPC-157 is studied primarily for its effects on growth factor signaling and vascular repair
But if the deficiency is in high levels, Vitamin B-12 injections are suggested as an ultimate measure
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted